370 related articles for article (PubMed ID: 23815986)
1. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.
Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
Am J Kidney Dis; 2013 Nov; 62(5):919-28. PubMed ID: 23815986
[TBL] [Abstract][Full Text] [Related]
2. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
[TBL] [Abstract][Full Text] [Related]
3. Association of a change in erythropoiesis-stimulating agent dose during hospitalization and subsequent hemoglobin levels and transfusions in hemodialysis patients.
Wong BC; Ravani P; Manns BJ; Lewin A; Zhang X; Chin R; Hemmelgarn BR; Tonelli M; Oliver MJ; Quinn RR
Am J Kidney Dis; 2013 Nov; 62(5):947-52. PubMed ID: 23856380
[TBL] [Abstract][Full Text] [Related]
4. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
[TBL] [Abstract][Full Text] [Related]
5. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
[TBL] [Abstract][Full Text] [Related]
6. Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness.
Edwards J; Morrison C; Mohiuddin M; Tchatalbachev V; Patel C; Schwickerath VL; Menitove JE; Singh G
Transfusion; 2012 Nov; 52(11):2445-51. PubMed ID: 22413968
[TBL] [Abstract][Full Text] [Related]
7. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.
Wetmore JB; Peng Y; Monda KL; Kats AM; Kim DH; Bradbury BD; Collins AJ; Gilbertson DT
Am J Nephrol; 2015; 41(4-5):354-61. PubMed ID: 26107376
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends in red blood transfusion among US dialysis patients, 1992-2005.
Ibrahim HN; Ishani A; Foley RN; Guo H; Liu J; Collins AJ
Am J Kidney Dis; 2008 Dec; 52(6):1115-21. PubMed ID: 18823686
[TBL] [Abstract][Full Text] [Related]
9. Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients.
Weinhandl ED; Gilbertson DT; Collins AJ
Am J Nephrol; 2011; 34(4):298-308. PubMed ID: 21829009
[TBL] [Abstract][Full Text] [Related]
10. Transfusion burden among patients with chronic kidney disease and anemia.
Lawler EV; Bradbury BD; Fonda JR; Gaziano JM; Gagnon DR
Clin J Am Soc Nephrol; 2010 Apr; 5(4):667-72. PubMed ID: 20299366
[TBL] [Abstract][Full Text] [Related]
11. Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices.
Liu J; Li S; Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
Am J Kidney Dis; 2014 Oct; 64(4):608-15. PubMed ID: 24820317
[TBL] [Abstract][Full Text] [Related]
12. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
Lacson E; Ofsthun N; Lazarus JM
Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
[TBL] [Abstract][Full Text] [Related]
13. Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003.
Solid CA; Foley RN; Gilbertson DT; Collins AJ
Hemodial Int; 2007 Oct; 11(4):442-7. PubMed ID: 17922742
[TBL] [Abstract][Full Text] [Related]
14. [Transfusion of recuperated blood in total knee arthroplasty].
Pitsaer E
Rev Chir Orthop Reparatrice Appar Mot; 2002 Dec; 88(8):777-89. PubMed ID: 12503019
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell transfusion use in patients with chronic kidney disease.
Gill KS; Muntner P; Lafayette RA; Petersen J; Fink JC; Gilbertson DT; Bradbury BD
Nephrol Dial Transplant; 2013 Jun; 28(6):1504-15. PubMed ID: 23389999
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.
Foley RN; Curtis BM; Parfrey PS
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1669-75. PubMed ID: 18922988
[TBL] [Abstract][Full Text] [Related]
17. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Abraham E; MacIntyre NR; Shabot MM; Duh MS; Shapiro MJ
Crit Care Med; 2004 Jan; 32(1):39-52. PubMed ID: 14707558
[TBL] [Abstract][Full Text] [Related]
18. Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates.
Molony JT; Monda KL; Li S; Beaubrun AC; Gilbertson DT; Bradbury BD; Collins AJ
Am J Kidney Dis; 2016 Aug; 68(2):266-276. PubMed ID: 26980607
[TBL] [Abstract][Full Text] [Related]
19. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]